AIM-listed infection prevention business Tristel (TSTL) is an attractive growth company with strong margins and a strong balance sheet. Given its potential to ‘clean up’ in the US market, where revenue is growing exponentially, it is also undervalued. Tristel makes and distributes chlorine dioxide for the healthcare sector, where surfaces and medical devices need disinfecting … Continue reading Find out how Tristel could ‘clean up’ in the US